Victory Capital Management Inc. reduced its holdings in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 21.3% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 947,223 shares of the company's stock after selling 256,460 shares during the period. Victory Capital Management Inc. owned about 0.36% of Ryan Specialty worth $62,886,000 at the end of the most recent reporting period.
Other large investors have also recently made changes to their positions in the company. Champlain Investment Partners LLC boosted its holdings in shares of Ryan Specialty by 28.0% during the first quarter. Champlain Investment Partners LLC now owns 4,937,332 shares of the company's stock worth $274,022,000 after purchasing an additional 1,079,505 shares during the period. Blair William & Co. IL lifted its holdings in Ryan Specialty by 3.4% in the 2nd quarter. Blair William & Co. IL now owns 2,866,003 shares of the company's stock worth $165,970,000 after buying an additional 94,663 shares during the period. Bessemer Group Inc. grew its position in shares of Ryan Specialty by 33.9% in the 1st quarter. Bessemer Group Inc. now owns 1,925,864 shares of the company's stock worth $106,886,000 after buying an additional 488,067 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Ryan Specialty by 148.9% during the third quarter. Principal Financial Group Inc. now owns 851,704 shares of the company's stock valued at $56,545,000 after acquiring an additional 509,548 shares in the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in Ryan Specialty by 132.2% in the second quarter. Bank of New York Mellon Corp now owns 836,209 shares of the company's stock worth $48,425,000 after acquiring an additional 476,126 shares during the period. 84.82% of the stock is owned by hedge funds and other institutional investors.
Ryan Specialty Price Performance
Shares of RYAN traded down $0.17 during trading hours on Friday, reaching $70.74. 172,364 shares of the stock traded hands, compared to its average volume of 871,679. Ryan Specialty Holdings, Inc. has a 52-week low of $41.49 and a 52-week high of $73.10. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $18.52 billion, a P/E ratio of 92.05, a price-to-earnings-growth ratio of 1.63 and a beta of 0.62. The company's 50-day moving average price is $68.14 and its two-hundred day moving average price is $61.66.
Ryan Specialty (NYSE:RYAN - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.41 EPS for the quarter, hitting analysts' consensus estimates of $0.41. The company had revenue of $604.69 million for the quarter, compared to the consensus estimate of $602.04 million. Ryan Specialty had a return on equity of 47.90% and a net margin of 10.31%. The firm's revenue for the quarter was up 20.5% on a year-over-year basis. During the same period in the previous year, the business earned $0.32 earnings per share. On average, analysts anticipate that Ryan Specialty Holdings, Inc. will post 1.8 earnings per share for the current year.
Ryan Specialty Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, November 26th. Stockholders of record on Tuesday, November 12th will be issued a $0.11 dividend. The ex-dividend date is Tuesday, November 12th. This represents a $0.44 annualized dividend and a dividend yield of 0.62%. Ryan Specialty's dividend payout ratio (DPR) is presently 57.14%.
Insider Activity at Ryan Specialty
In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 35,000 shares of Ryan Specialty stock in a transaction on Monday, August 19th. The stock was sold at an average price of $64.69, for a total transaction of $2,264,150.00. Following the completion of the sale, the director now directly owns 19,251 shares of the company's stock, valued at $1,245,347.19. The trade was a 64.51 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Mark Stephen Katz sold 14,790 shares of the company's stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $71.39, for a total transaction of $1,055,858.10. Following the completion of the sale, the executive vice president now directly owns 12,386 shares of the company's stock, valued at approximately $884,236.54. This trade represents a 54.42 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 94,193 shares of company stock worth $6,208,493. Insiders own 11.10% of the company's stock.
Analyst Upgrades and Downgrades
Several research firms have weighed in on RYAN. BMO Capital Markets raised Ryan Specialty from a "market perform" rating to an "outperform" rating and lifted their price objective for the company from $65.00 to $75.00 in a research report on Tuesday, September 24th. JPMorgan Chase & Co. raised their price objective on Ryan Specialty from $54.00 to $56.00 and gave the company an "underweight" rating in a research report on Friday, August 2nd. Citigroup lifted their price target on shares of Ryan Specialty from $56.00 to $62.00 and gave the company a "neutral" rating in a research report on Tuesday, July 23rd. Wells Fargo & Company raised their price objective on shares of Ryan Specialty from $63.00 to $70.00 and gave the company an "equal weight" rating in a research note on Thursday, October 10th. Finally, The Goldman Sachs Group raised their price target on shares of Ryan Specialty from $64.00 to $72.00 and gave the company a "neutral" rating in a research report on Wednesday, October 9th. One research analyst has rated the stock with a sell rating, five have given a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $70.33.
Get Our Latest Analysis on RYAN
About Ryan Specialty
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Articles
Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.
Get This Free Report